CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
For the period ended Sep 26, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 26, 2026 · Filed Nov 4, 2026
CRL$345.80-2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income (Unaudited)
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |
| Net income | $334,444 | $55,556 | $318,882 | $134,127 |
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustment | 4,599 | (26,962) | (30,097) | 154,639 |
| Amortization of net loss, settlement losses, and prior service benefit included in total cost for pension and other post-retirement benefit plans | 895 | 462 | 2,682 | 1,327 |
| Other comprehensive income (loss), before income taxes | 5,494 | (26,500) | (27,415) | 155,966 |
| Less: Income tax expense (benefit) related to items of other comprehensive income | 114 | (952) | (7,601) | 28,967 |
| Comprehensive income, net of income taxes | 339,824 | 30,008 | 299,068 | 261,126 |
| Less: Comprehensive income related to noncontrolling interests, net of income taxes | 1,459 | 735 | 1,234 | 3,180 |
| Comprehensive income attributable to Charles River Laboratories International, Inc., net of income taxes | $338,365 | $29,273 | $297,834 | $257,946 |
| See Notes to Unaudited Condensed Consolidated Financial Statements. | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.